The association of delta neutrophil index with the prognosis of acute exacerbation of chronic obstructive pulmonary disease

被引:9
|
作者
Park, Sunmin [1 ]
Lee, Sang Jun [1 ]
Shin, Beomsu [1 ]
Lee, Seok Jeong [1 ]
Kim, Sang-Ha [1 ]
Kwon, Woo Cheol [2 ]
Kim, Jihye [3 ]
Lee, Myoung Kyu [1 ,4 ]
机构
[1] Yonsei Univ, Wonju Coll Med, Dept Internal Med, 20 Ilsan Ro, Wonju 26426, Gangwon Do, South Korea
[2] Yonsei Univ, Wonju Coll Med, Dept Radiol, Wonju, Gangwon, South Korea
[3] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL USA
[4] Yonsei Univ, Wonju Coll Med, Dept Evidence Based Med, Wonju, Gangwon, South Korea
关键词
Acute exacerbation; Chronic obstructive pulmonary disease; Community-acquired pneumonia; Delta neutrophil index; Mortality; Readmission; COMMUNITY-ACQUIRED PNEUMONIA; COPD; MORTALITY; GUIDELINES; MANAGEMENT; DIAGNOSIS; SEPSIS; COUNTS; MARKER; ADULTS;
D O I
10.1186/s12890-020-1083-4
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with infective triggers including bacterial or viral in many cases, and pneumonia is a major contributor to hospitalization for AECOPD and has a close relationship with poor outcomes. Increased delta neutrophil index (DNI) can be useful in the detection of COPD patients with pneumonia. Methods A retrospective cohort study was performed to investigate the mortality rate of the patients who were re-admitted within 6 months after discharge from the hospital due to AECOPD with or without CAP. We analyzed the difference of cumulative survival rate according to serum DNI level and readmission duration. Results Finally, 140 AECOPD patients with community-acquired pneumonia (CAP) and 174 AECOPD patients without CAP were enrolled during 6 months, respectively. The mean age was 72.2 +/- 9.4 year-old, and 240 patients (76.4%) were male. When comparing the cumulative survival rate according to readmission duration (<= 30 vs > 30 days) and DNI level (< 3.5 vs >= 3.5%), AECOPD patients with readmission <= 30 days and DNI >= 3.5% showed the lowest cumulative survival rate compared to other groups (P < 0.001). Multivariate analysis revealed readmission duration <= 30 days (HR 7.879, 95% CI 4.554-13.632, P < 0.001); and serum DNI level (HR 1.086, 95% CI 1.043-1.131, P < 0.001) were significantly associated with the mortality of AECOPD patients during 6 months. The area under the curve for readmission (<= 30 days) + DNI level (>= 3.5%) was 0.753 (95% CI 0.676-0.830, P < 0.001) with a sensitivity of 73.7% and a specificity of 67.3%. Conclusion AECOPD patients who were readmitted <= 30 days and DNI >= 3.5% showed higher mortality. DNI level can be used as a predictor of prognosis in AECOPD patients who were readmitted after discharge.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] NEUTROPHIL-TO-LYMPHOCYTE RATIO AS A MARKER OF ACUTE EXACERBATION AND DISEASE SEVERITY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Sekkizhar, Usha
    Paulose, Anoop
    Balaji, Thiriveni G. S.
    Ramaraj, Jegatheesh
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (43): : 4651 - 4658
  • [22] Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Iyer, Anand S.
    Bhatt, Surya P.
    Garner, Jeffrey J.
    Wells, J. Michael
    Trevor, Jennifer L.
    Patel, Neha M.
    Kirkpatrick, deNay
    Williams, John C.
    Dransfield, Mark T.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (02) : 197 - 203
  • [23] Improving Adherence for Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Sonstein, Lindsay
    Clark, Carlos
    Seidensticker, Susan
    Zeng, Li
    Sharma, Gulshan
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (11): : 1097 - 1104
  • [24] Complexity in clinical diagnoses of acute exacerbation of chronic obstructive pulmonary disease
    Pratt, Alexandre J.
    Purssell, Andrew
    Zhang, Tinghua
    Luks, Vanessa P. J.
    Bauza, Xavier
    Mulpuru, Sunita
    Kirby, Miranda
    Aaron, Shawn D.
    Cowan, Juthaporn
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [25] Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease
    Wang, Rui-tao
    Li, Jia-Ying
    Cao, Zhi-gang
    Li, Ying
    RESPIROLOGY, 2013, 18 (08) : 1244 - 1248
  • [26] Association of obstructive sleep apnoea with acute severity of chronic obstructive pulmonary disease exacerbation: a population-based study
    Hirayama, Atsushi
    Goto, Tadahiro
    Faridi, Mohammad K.
    Camargo, Carlos A.
    Hasegawa, Kohei
    INTERNAL MEDICINE JOURNAL, 2018, 48 (09) : 1150 - 1153
  • [27] The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease
    Boudestein, Laura C. M.
    Rutten, Frans H.
    Cramer, Maarten J.
    Lammers, Jan Willem J.
    Hoes, Arno W.
    EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (12) : 1182 - 1188
  • [28] Spectrum and antimicrobial resistance in acute exacerbation of chronic obstructive pulmonary disease with pneumonia: a cross-sectional prospective study from Vietnam
    Dao, Duy Tuyen
    Le, Huu Y.
    Nguyen, Minh Hai
    Thi, Thi Duyen
    Nguyen, Xuan Dung
    Bui, Thanh Thuyet
    Tran, Thi Huyen Trang
    Pham, Van Luan
    Do, Hang Nga
    Horng, Jim-Tong
    Le, Huu Song
    Nguyen, Dinh Tien
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [29] HsCRP in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Alavi, S. A.
    Soati, F.
    Forghanparast, K.
    Amani, H.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2011, 13 (10) : 713 - 718
  • [30] Can Glasgow score predict mortality in patients with chronic obstructive pulmonary disease with acute exacerbation?
    Guldaval, Filiz
    Anar, Ceyda
    Gayaf, Mine
    Yavuz, Melike Y.
    Polat, Gulr
    Ayranci, Aysu
    Karadeniz, Gulistan
    Ucsular, Fatma
    Buyuksirin, Melih
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2021, 70 (03): : 351 - 356